B. Riley Boosts Core Scientific (NASDAQ:CORZ) Price Target to $14.00

Core Scientific (NASDAQ:CORZFree Report) had its price objective increased by B. Riley from $13.00 to $14.00 in a research report report published on Friday morning, Benzinga reports. The firm currently has a buy rating on the stock. B. Riley also issued estimates for Core Scientific’s FY2026 earnings at $0.22 EPS.

Several other research firms have also recently commented on CORZ. BTIG Research increased their target price on Core Scientific from $10.00 to $15.00 and gave the company a buy rating in a research note on Wednesday, June 26th. Sanford C. Bernstein reiterated an outperform rating and set a $17.00 price objective on shares of Core Scientific in a research note on Tuesday, September 10th. Canaccord Genuity Group began coverage on shares of Core Scientific in a research report on Monday, September 23rd. They issued a buy rating and a $16.00 target price for the company. Needham & Company LLC began coverage on shares of Core Scientific in a research note on Wednesday, September 4th. They issued a buy rating and a $16.00 target price on the stock. Finally, Cantor Fitzgerald reiterated an overweight rating and issued a $20.00 price target on shares of Core Scientific in a research note on Thursday, October 3rd. Eleven investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of Buy and a consensus price target of $15.27.

Check Out Our Latest Stock Report on CORZ

Core Scientific Trading Down 1.9 %

Shares of CORZ stock opened at $12.97 on Friday. The company’s fifty day moving average price is $10.90 and its two-hundred day moving average price is $8.07. Core Scientific has a 12 month low of $2.61 and a 12 month high of $13.42.

Core Scientific (NASDAQ:CORZGet Free Report) last released its quarterly earnings results on Wednesday, August 7th. The company reported ($4.51) EPS for the quarter, missing the consensus estimate of ($0.04) by ($4.47). The company had revenue of $141.10 million during the quarter, compared to analyst estimates of $128.58 million. The business’s revenue was up 11.2% on a year-over-year basis. On average, analysts anticipate that Core Scientific will post 0.01 EPS for the current year.

Insider Transactions at Core Scientific

In related news, CFO Denise Marie Brucia Sterling sold 8,752 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $9.41, for a total transaction of $82,356.32. Following the completion of the transaction, the chief financial officer now owns 122,217 shares in the company, valued at $1,150,061.97. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Core Scientific news, insider Todd M. Duchene sold 11,582 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $108,986.62. Following the sale, the insider now owns 1,686,474 shares in the company, valued at approximately $15,869,720.34. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Denise Marie Brucia Sterling sold 8,752 shares of the stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $9.41, for a total value of $82,356.32. Following the completion of the transaction, the chief financial officer now directly owns 122,217 shares of the company’s stock, valued at $1,150,061.97. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have purchased 12,761 shares of company stock worth $127,080. 32.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Fiduciary Alliance LLC bought a new stake in shares of Core Scientific during the first quarter valued at about $84,000. Hexagon Capital Partners LLC acquired a new position in Core Scientific during the 1st quarter valued at about $34,000. Perigon Wealth Management LLC bought a new stake in shares of Core Scientific during the 1st quarter worth about $688,000. Capstone Investment Advisors LLC acquired a new stake in shares of Core Scientific in the 1st quarter worth approximately $307,000. Finally, Concurrent Investment Advisors LLC acquired a new stake in shares of Core Scientific in the 1st quarter worth approximately $417,000.

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Featured Articles

Analyst Recommendations for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.